Civilization Ventures Management, Llc β Full Portfolio
66 tracked investments Β· listed companies and verified rows first
BillionToOne is a precision diagnostics company that uses molecular counting technology to develop non-invasive prenatal screening and liquid biopsy tests for early disease detection.
BiotechDigital HealthHealthtechMedical DevicesSan Francisco, US
Oguzhan Atay, PhD(Co-Founder, CEO, and Board Chair)David Tsao, PhD(Co-Founder, CTO, and Board Member)Oguzhan Atay(Founder)inDavid Tsao(Founder/CTO)inSukrit Silas(Cofounder)
Co-investors500 Emerging Europe500 GlobalAsymmetry Venturese2vcFifty YearsFriale+15 more
Omada Health provides virtual-first, integrated care programs for chronic disease management, delivered as data-driven solutions for employers, health plans, and healthcare organizations.
Digital HealthHealthtechWellness & FitnessSan Francisco, US
Andrew DiMichelle(Executive Officer, Director)Adrian James(Executive Officer, Director)Sean Duffy(Executive Officer, Director)Wei-Li Shaoin
BoardJonathan Root(Director)inCasper De Clercq(Director)in
Co-investorsAndreessen HorowitzBlackbird GiantsCanvas VenturesDesigner FundFounder CollectiveHealthtech Capital+12 more
Oxford Cancer Analytics develops a diagnostics platform that combines reproducible proteomic measurement with AI to produce evidence-based insights supporting clinical decision-making.
AI & Machine LearningBiotechMedical DevicesOxford, GB
Andreas Halner(Founder and Head of Healthcare AI)inHeinrich Roder(Chief Technology Officer)inDaniel Szulc(Chief Product Officer)in
Co-investorsEka VenturesCross-Border Impact VenturesMeridian Health VenturesUK Innovation & Science Seed FundDigitalDx VenturesOnstage+1 more
10x provides an AI-powered back-office service that automates dental practice operations including hygiene recall outreach, treatment follow-up coordination, and missed-call answering.
AI & Machine LearningHealthtechSaaSSan Francisco, US
Co-investorsY CombinatorInitialized Capital
10x Science provides an AI platform that automates protein characterization for drug developers, reducing months of manual analysis to speed the evaluation of therapeutic candidates in early-stage development.
AI & Machine LearningBiotechEnterprise SoftwareSaaSSan Francisco, US
David Roberts(Founder and CEO)inAndrew Reiter(Founder and COO)inVishnu Tejus(Founder and CTO)in
Co-investorsInitialized CapitalY Combinator
23andMe operates a research platform that collects genetic data from millions of users to advance genomic research and health discovery.
BiotechDigital HealthDirect to ConsumerHealthtechLongevityMountain View, US
Anne Wojcicki(Co-founder & CEO)inLinda Avey(Co-founder)Paul Cheung(Co-founder)Andrew Page(Executive Officer, Director)Kathy Hibbs(Executive Officer)
BoardEsther Dyson(Director)
Co-investorsAllied Venture PartnersEQUIAMG SquaredHouston Angel NetworkInvestXJazzya Investments+12 more
Adyn uses large inclusive datasets and machine learning to advance personalized medicine for historically under-researched health conditions, with initial focus on reproductive disorders.
AI & Machine LearningDigital HealthHealthtechMedical DevicesWellness & FitnessSeattle, US
Elizabeth Ruzzo(Founder, CEO)Elizabeth Ruzzo, PhD(Founder)in
Co-investorsAscend Venture CapitalDuke Capital PartnersWestbound Equity PartnersY Combinator
Aikium combines deep learning with large-scale wet-lab experimentation to design and screen protein libraries, aiming to develop protein therapeutics for hard-to-treat targets such as GPCRs and ion channels.
AI & Machine LearningBiotechDeep Tech
Eswar I(Founder)Shankar Shastry(Founder)Venkatesh Mysore(Founder)Dr. Eswar Iyer(CEO | Head of Synthetic Biology)Michael Tolentino(Chief Development Officer)inDr. Shankar Shastry(Vice President | Head of Protein Sciences)
Co-investorsBantam Group
Alveo Technologies makes a palm-sized molecular diagnostic analyzer with preloaded test cartridges that deliver on-site pathogen results in under an hour, with results sent to a smartphone.
AgTechBiotechMedical DevicesAlameda, US
Ron Chiarello(Executive Officer, Director)Michael Aicher(Executive Officer, Director)Shaun Holt(Chairman of the Board & Chief Executive Officer)Erik Tyrrell-Knott(President & Chief Business Officer)Scott(Chief Commercial Officer)Slava Elagin(Executive (R&D/Operations))
Co-investorsBlack Diamond VenturesCelesta CapitalCelesta CapitalPartners ResoluteSUPPLY CHANGE CAPITAL
Ample builds a modular battery-swapping technology that delivers a full charge to any electric vehicle in under five minutes using lego-like swappable battery modules, without requiring carmakers to redesign their cars.
CleantechEnergyMobility & Transportation
Co-investorsJazzya InvestmentsNew Ground VenturesStart CapitalTransform Capital ManagementXYZ Venture CapitalEnergy & Environment Investment+4 more
Antheia uses a yeast-based biosynthesis and fermentation platform to manufacture Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs) for essential medicines, offering an alternative to fragile agricultural sourcing.
Advanced ManufacturingBiotechHealthtechMenlo Park, US
Christina D. Smolke(Executive Officer, Director)Christina Smolke(Co-Founder & CEO)inKristy Hawkins(Co-Founder & CSO)inEric d'Esparbes(Chief Financial Officer)inZack McGahey(Chief Operating Officer)inHeidi Pucel(Chief People Officer)in
Co-investorsAmerica's Frontier FundLam CapitalSherpalo VenturesGlobal Health Investment Corporation
Aperiam Bio uses computer-vision algorithms to identify "hyperfolding" protein variants with improved expression, solubility, and stability, aiming for order-of-magnitude gains in protein performance.
AI & Machine LearningBiotechDeep TechAustin, US
Austin Cole(CEO & Founder)Guillaume Cottarel(Head of Program)Russell Durrett(Chief Business Officer)
Co-investorsOMX VenturesAxial VCKdT Ventures
Aspect Biosystems develops bioprinted tissue therapeutics using a platform that combines AI-powered bioprinting, computational design tools, therapeutic cells, and biomaterials to create implantable allogeneic tissues.
AI & Machine LearningBiotechLongevity
Tamer Mohamed(Founder & CEO)inSam Wadsworth(Co-founder & Chief Scientific Officer)inSimon Beyer(Co-founder & Chief Technology Officer)inLeela Paris(Chief Technical Operations Officer)inMike Scott(Chief Development Officer)inRay Smith(Chief Financial Officer)in
Co-investorsAngel ForumInBC Investment Corp.JDRF T1D FundPage One VenturesPallasite VenturesPangaea Ventures Us Inc.+4 more
Axonis Therapeutics is a biotechnology company developing small-molecule medicines that target KCC2, a mediator of inhibition in the brain, to treat neurological disorders such as epilepsy and pain.
BiotechDeep TechBoston, US
Shane Hegarty(Executive Officer)Shane V. Hegarty(Chief Scientific Officer & Co-Founder)Jeffrey Imbaro(Executive Officer)Joanna Stanicka(Chief Executive Officer, President & Co-Founder)inJeff Imbaro(Chief Operating Officer)Tiasha Shafiq(Chief of Staff)
Co-investorsvenBio PartnersMRL Ventures FundSofinnova VenturesCreative Destruction Lab (CDL)Hatteras Venture PartnersIaso Ventures+7 more
Babyscripts provides a maternity care platform with remote patient monitoring, risk screening, and care management services for pregnant and postpartum patients.
Digital HealthFemTechHealthtech
Co-investorsCU Healthcare Innovation FundMemorialCare Innovation FundPhilips VenturesBuilders + BackersIrishAngelsK Street Capital+4 more
Biomemory develops DNA-based data storage systems for data centers, offering an alternative storage tier optimized for long-term archival, density, and energy efficiency.
Climate TechData & InfrastructureDeep Tech
Co-investorsFifty YearsHemisphere Ventures LLCNew Enterprise Associates (NEA)Prefix CapitalZ Venture CapitalCantos Ventures+3 more
Catena develops a conjugation platform for antibody-drug conjugates (ADCs) and multi-payload conjugates used in oncology for solid tumors.
BiotechDeep TechHealthtechMedical DevicesSan Francisco, US
Marco Lobba(Founder)inMatthew Francis(Founder)in
Co-investorsIaso VenturesY CombinatorAxial VCLongeVCMBX CapitalSocial Impact Capital
Convergent Genomics is a genomic diagnostics company that uses next-generation sequencing and liquid biopsy to extract DNA from urine and detect, monitor, and predict urothelial (bladder) cancer non-invasively.
AI & Machine LearningBiotechDigital Health
Trevor Levin(Founder, President & Chief Scientific Officer)Brian Slingerland(Chief Executive Officer)Brian Mazzarella(Chief Medical Officer)Iden Haddadzadeh(Chief Operating Officer)
Curai Health offers virtual primary care through a chat-based service, connecting patients with a care team of medical experts for diagnosis, treatment, prescription renewals, and management of conditions such as flu, hypertension, and diabetes.
AI & Machine LearningDigital HealthHealthtech
Co-investorsWestRiver Group
Curve Pay is a digital wallet that combines multiple bank cards into one, letting users switch which card paid for a purchase after the fact, avoid foreign exchange fees, and earn cashback on top of existing card rewards.
ConsumerFintech
Shachar Bialick(Founder & CEO)
Co-investorsCohen CircleFuel Venture CapitalHanaco Venture CapitalLifeX VenturesMouro CapitalOutward VC+7 more
Delineate builds AI agents that help pharmaceutical companies design clinical trials more quickly by converting existing trial research into specialized datasets, reducing the time scientists spend on trial preparation.
AI & Machine LearningBiotechDeveloper ToolsEnterprise SoftwareSaaSBoston, US
Emily Nieves(Founder)inJawad Iqbal(Founder)in
Co-investorsY Combinator
DermBiont develops SM-030, a topical drug candidate targeting melasma, a skin pigmentation disorder, by inhibiting PKC-beta to address the underlying cause of hyperpigmentation.
BiotechDigital HealthMedical DevicesBoston, US
Robert Brucker(Executive Officer)Karl R. Beutner(Executive Officer, Director)Nichola Eliovits(Executive Officer, Director)inMax Dawson(Executive Officer)
BoardWilder Ramsey(Director)inJennifer Lee(Director)
Co-investorsJoyance PartnersOlive Tree CapitalStart CapitalToba CapitalValia VenturesNewpath Partners
Co-investorsDCVC (Data Collective)Molten VenturesStart Capital
Co-investorsAbstract VenturesAdjuvant CapitalCota CapitalGreatPoint VenturesNorwest Venture PartnersToba Capital+1 more
One Health operates a clinical trial platform using canine cancer data to accelerate and de-risk human oncology drug development.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesSan Francisco, US
Christina Lopes(Co-Founder & CEO)inBen Lewis(Co-founder)Benjamin Lewis(Co-Founder)inchristina lopes(Founder)in
Co-investorsAndreessen HorowitzaVentureGlobal BrainMaC Venture CapitalMyAsiaVCOncology Ventures+5 more
Fluent Bio develops software for analyzing single-cell RNA sequencing data, producing count matrices and diagnostic outputs for researchers using Illumina sequencing libraries.
BiotechDeveloper Tools
Co-investorsCota CapitalIllumina VenturesSamsara BioCapital
Cancer recurrence testing platform acquired by Natera.
Foresight Diagnostics develops ultra-sensitive molecular diagnostic tests that combine genomics and bioinformatics to detect minimal residual disease and circulating tumor DNA across multiple cancer types.
BiotechDigital HealthHealthtechBoulder, US
Co-investorsAgent Capital
Glyphic Biotechnologies develops ProSEβ’, a high-throughput de novo protein sequencing technology for analyzing proteomes with single-molecule sensitivity.
BiotechDeep TechBerkeley, US
Joshua Yang(Founder & CEO)Daniel Estandian(Founder)Ed Boyden(Founder)Josh Yang(Founder)in
BoardCraig Asher(Director)inJimmy Yun(Director)
Co-investorsArtis VenturesBlack FlagFoundersX VenturesLongeVCModi VenturesOMX Ventures+3 more
Iantrek develops micro-interventional ophthalmic surgical technologies focused on enhancing total outflow through the uveoscleral pathway to treat glaucoma.
BiotechHealthtechMedical DevicesElkins Park, US
Tsontcho Ianchulev(Executive Officer, Director)Sean Ianchulev(Founder & Chairman of the Board (CMO))Michael Haydin(Executive Officer)
BoardJeffry K Weinhuff(Director)Farrell Tyson(Director)Stephen Bloch(Director)in
Co-investorsaMoonVisionary VenturesCanaan PartnersFemHealth VenturesJSD Capital, LLCUS Venture Partners
J.P.
Enterprise SoftwareFintechNew York City, US
Co-investors8VCBelief CapitalLux CapitalSilent VenturesSV AngelY Combinator
Infinimmune discovers and develops antibody therapeutics using proprietary sequencing technology and AI-powered optimization.
AI & Machine LearningBiotechMedical Devices
Lance Hepler(Founder)inKatie Pfeiffer(Founder)Michael Gibbons(Founder)Wyatt McDonnell(Founder)david jaffe(Founder)
Co-investorsPlayground GlobalAxial VC
Insamo develops an automated platform for drug discovery that designs, synthesizes, and tests cyclic peptides at scale using machine learning and proprietary experimental data.
AI & Machine LearningBiotechDeep TechChippendale, AU
TIMOTHY CRAVEN(Executive Officer, Director)TOBY PASSIOURA(Executive Officer, Director)Tim Craven(CEO)Toby Passioura(CSO)Glen McIntyre(COO)GLEN MCINTYRE(Executive Officer, Director)
Co-investorsMRL Ventures FundPlayground GlobalvenBio PartnersAxial VCvenBio Global Strategic
Integrated Biosciences is a biotech company developing small molecule therapeutics for age-related diseases, using optogenetics, chemistry, and AI to study aging biology.
AI & Machine LearningBiotechLongevityRedwood City, US
Felix Wong(Executive Officer, Director)inDaniel J. Anderson(Chief Scientific Officer)Themasap Khan(Director)
BoardKeith Loebner(Director)
Co-investorsSutter Hill VenturesIllumina Ventures
Invitae provides genetic testing services to patients and clinicians across the United States, offering broad test offerings and genetic counseling to inform health decisions at every stage of life.
BiotechDigital HealthHealthtechMedical DevicesSan Francisco, US
Sean George(Executive Officer, Director)Randal Scott(Executive Officer, Director)Shelly Guyer(Executive Officer)Lee Bendekgey(Executive Officer)Geoffrey Crouse(Director)
BoardEric Aguiar(Director)in
Co-investorsDecheng CapitalFifty YearsManta Ray VenturesOberland CapitalPrefix CapitalTech Wildcatters+1 more
JustPaid is a B2B billing automation platform that uses AI to create, send, and track invoices, run collections, and reconcile payments across tools like Stripe, QuickBooks, Xero, and Salesforce.
AI & Machine LearningFintechSaaS
Co-investorsTRAC (Third Round Analytics Capital)
Kernal Bio is a synthetic biology company developing selective mRNA drugs to treat serious illnesses, with a focus on cancer therapeutics and improving patient outcomes.
AI & Machine LearningBiotechHealthtechMedical DevicesBoston, US
Yusuf Erkul(Founder)inJeff Ozdemir(Founder)inBurak Yilmaz(Founder)inBurak YILMAZ(Founder)inCatherine Moroski(Executive Officer, Director)Oguzhan Yilmas(Director)
Co-investorsAsymmetry VenturesFoundersX VenturesHOF CapitalHummingbird VenturesSAV (Scale Asia Ventures)Y Combinator
Co-investorsCapria Ventures
Lemonaid Health is a telehealth company that lets patients access medical care and treatment online from home, including services like contraceptive pill prescriptions and UTI treatment.
ConsumerDigital HealthDirect to ConsumerHealthtechSan Francisco, US
Co-investorsArtis VenturesCorrelation VenturesDaybreak PartnerseGateway CapitalFirebolt Ventures Management Company, LlcHikma Ventures+4 more
Manus Bio uses industrial biotechnology and engineered microbial cell factories to produce "BioAlternatives" β sustainable versions of molecules normally sourced from petrochemicals, agriculture, or animal husbandry β and offers a scale-up platform covering cell factory design through biomanufacturing.
BiotechFoodTechNew MaterialsAugusta, US
Ajikumar Parayil(Executive Officer, Director)Aji Parayil(Co-founder)Greg Stephanopoulos(Co-founder)Gregory Stephanopoulos(Director)
BoardJason Whaley(Director)inCarsten Boers(Director)in
Co-investors+ND CapitalEnergy Impact PartnersLiebenthal VenturesNelstone VenturesNXT VenturesPrefix Capital+2 more
Nanite develops resorbable polymer nanoparticles (PNPs) for virus-free genetic drug delivery, using high-throughput synthesis and AI to design precision delivery vectors for gene therapy.
AI & Machine LearningBiotechDeep TechBoston, US
Shashi Murthy(Executive Officer)Sean Kevlahan(Co-founder & CEO)Thomas X. Neenan(Executive Officer)Thomas Neenan(Co-founder & CBO)
Co-investorsBantam Group
Outpace Bio develops engineered protein technologies and cell therapies to treat solid tumors, focusing on protein design and T cell engineering to improve cancer treatment efficacy and safety.
BiotechDeep TechMedical DevicesSeattle, US
Marc Lajoie(Co-founder & Chief Executive Officer)Scott Boyken(Co-founder & Chief Technology Officer)Stanley Riddell(Co-Founder and Scientific Advisor)Aaron Foster(Executive Officer)Charity Scripture(Executive Officer)Eric Soller(Executive Officer)
Co-investorsArtis VenturesRA CapitalAbstract VenturesAtinum Investment Co. Ltd.Modi VenturesPlayground Global+1 more
Overt Bio develops cell therapies that link genes to immune functions using genome-scale discovery platforms.
AI & Machine LearningBiotechMedical DevicesNew York, US
Dr. Legut(Co-Founder and CEO)Dr. Sanjana(Co-Founder)Mateusz Legut(Executive Officer, Director)Neville Sanjana(Director)Mat Legut(Founder)in
BoardVasudev Bailey(Director)in
Co-investorsArtis VenturesFusionHAWKTAILWingAlexandriaGaingels+1 more
This page is a distribution, marketing, and reseller partner directory for PRWeb, an online press release distribution service.
Marketing TechMedia & EntertainmentSaaS
Co-investorsAdvance Venture PartnersAngel Physicians FundAvestria VenturesAviv Venture CapitalBIGR VenturesBlue Venture Funds+15 more
Ermit designs and manufactures connected hardware devices with embedded software and AI capabilities, serving companies building IoT and field-operated products.
CybersecurityHardwareIoT
Co-investorsHikma VenturesSamsung VenturesStanley Ventures
Prellis Biologics runs an antibody discovery platform that uses two-photon laser-bioprinted human immune organoids combined with machine learning to identify fully human antibody therapeutics.
AI & Machine LearningBiotechDeep TechHayward, US
Melanie Matheu(Executive Officer, Director)Noelle Mullin(Executive Officer, Director)
BoardArvind Gupta(Director)Rohit Sharma(Director)in
Co-investorsBlack Diamond VenturesOpen Field CapitalPrefix CapitalCantos VenturesCelesta CapitalKhosla Ventures+2 more
QUiCKR develops rapid genetic modification quantification kits for cell and gene therapy R&D programs, analyzing structural variants, edits, and genome integrity to accelerate development timelines and reduce costs.
BiotechDeep TechMedical Devices
Charles Blanluet(Founder)in
Co-investorsHCVCLexi Ventures
Range Bio (Range Biotechnologies) develops next-generation diagnostics using translational proteomics for applications in human health.
BiotechHealthtechMedical Devices
Brandon Wilson, Ph.D.(Co-founder & CEO)Brandon Wilson(Co-founder & CEO)
Co-investorsArtis VenturesFifty YearsHAWKTAILPage One VenturesPear VCPillar
Gene editing pioneer and founding investment acquired by Intellia for $200M.
Gene editing company, with Civilization as founding investor, acquired by Intellia for $200M.
Co-investorsPrefix Capital
Rocket Pharmaceuticals develops gene therapies to treat patients with rare genetic diseases, focusing on cardiovascular and hematologic disorders.
BiotechDigital HealthMedical Devices
Gaurav Shah(Co-founder & Chief Executive Officer)
BoardRoderick Wong(Director)inNaveen Yalamanchi(Director)in
Co-investorsAvoro Capital AdvisorsBroadview VenturesRTW Investments L.P.
R-Zero provides AI software that reduces HVAC energy consumption in buildings by 20-40% using real-time occupancy and air quality data, with no infrastructure changes required.
CleantechEnterprise SoftwareIoT
Co-investorsDBL PartnersLeadout CapitalQualcomm VenturesUpfront Ventures
Sensible Biotechnologies develops a cell-based mRNA design and manufacturing platform that produces pure, low immunogenicity mRNA therapeutics for drug development.
AI & Machine LearningBiotechDeep TechHealthtechOxford, GB
Miroslav Gasparek(Founder)inMarian Kupculak(Founder)in
Co-investorsKAYARecode VenturesY CombinatorZAKA VCBlueYard Capital
Genetic screening platform for early pregnancy, acquired by Invitae.
HealthtechSan Francisco, US
Jones Hywel(Executive Officer, Director)
BoardEli Casdin(Director)
Siren Biotechnology develops next-generation AAV (adeno-associated virus) platforms for gene therapy applications, including gene repair, gene transfer, and gene editing.
BiotechDigital HealthMedical DevicesSan Francisco, US
Dr. Nicole Paulk(CEO, Founder, and President)Nicole Paulk(Executive Officer, Director)Lauren Kelly(Founder)inSharon Tetlow(Director)Brad Allen(Director)
Co-investorsArtis VenturesAvilaCarnrite VenturesHAWKTAILNZVCPlum Alley Investments+2 more
Tahoe Bio AI applies machine learning and computational biology to drug discovery and development.
AI & Machine LearningBiotechDeep Tech
Co-investorsAIX VenturesAmplify PartnersWingDatabricks Ventures
Teiko provides CLIA-validated high-dimensional cytometry servicesβincluding spectral flow and mass cytometry panels, blood preservation kits, gating, and a data analysis dashboardβfor immune cell profiling in clinical trials.
BiotechDigital HealthHealthtechSalt Lake City, US
Ramji Srinivasan(Executive Officer, Director)inMatt(Co-founder)inMatthew Spitzer(Director)
BoardVictor Wang(Director)in
Co-investorsHAWKTAILHOF CapitalTau VenturesTwine VenturesWestern Technology Investment
TenSixty uses machine learning and cell biology expertise to identify novel antibody targets on cancer cells for the development of new cancer therapeutics.
AI & Machine LearningBiotechMedical DevicesCambridge, US
Daniel Montoro(Executive Officer, Director)inKarthik Jagadeesh(Executive Officer, Director)Christoph Muus(Director)
BoardDipchand Nishar(Director)Sara Choi(Director)
Co-investorsGeneral CatalystWing
Tigatx develops engineered IgA antibodies designed to engage neutrophils as a cancer treatment approach.
Biotech
Co-investorsBioGeneration Ventures
uLab Systems builds digital orthodontics tools, including software (uDesign, uAssist) and uSmile clear aligners manufactured in the USA, for dental professionals and orthodontic practices.
BiotechDigital HealthHealthtechMedical DevicesSaaSMemphis, US
AmirAli Talasaz(Director)Mark Foley(Director)David Thrower(Executive Officer)Tim Dumore(Director)Rita O'Connor(Director)Robert Doty(Executive Officer)
Co-investors7 Gate VenturesAPERTURE Venture PartnersTachles VC
Verbal is an AI platform that audits healthcare interactionsβincluding calls, video telemedicine, clinical notes, and chatβto ensure compliance with internal protocols and external standards like TJC and URAC.
AI & Machine LearningDigital HealthHealthtechSaaSCovina, US
Eric Lee Escobedo WuWaleed Mohsen
Co-investors500 GlobalAUTHENTIC VENTURESCosmic Venture PartnersEast Post Road VenturesK20 FundTechstars+1 more
Wild Earth manufactures plant-based dog food formulated to meet nutritional standards while reducing environmental impact compared to traditional meat-based pet food.
Circular EconomyConsumerFoodTechHealthtech
Co-investorsAt One VenturesBabel VenturesBig Idea VenturesMaC Venture CapitalOssian CapitalSimon Capital+2 more
Wyndly provides personalized allergy treatment through board-certified doctors, delivering clinical immunotherapy and testing directly to patients' homes without requiring office visits.
Digital HealthHealthtechWellness & FitnessNew York City, US
Aakash Shah(Founder & CEO)inManan Shah(Founder)in
Co-investorsImmeasurableY CombinatorGoodwater Capital
xCures builds an AI platform that assembles and structures fragmented medical records into organized, decision-ready clinical data for healthcare organizations.
AI & Machine LearningData & InfrastructureDigital HealthHealthtechOakland, US
Mika Newton(Chief Executive Officer)Glenn Kramer(Chief Technology Officer)Kenny Wong(Chief Product Officer)
Co-investorsHarmonix FundHealthtech CapitalInnovius CapitalLauder PartnersMetaplanetPortfolia+4 more
YourChoice Therapeutics is developing YCT-529, a non-hormonal oral contraceptive for men currently in Phase 2 clinical trials.
BiotechFemTechHealthtech
Akash Bakshi, MSc(Co-founder & CEO)Nadja Mannowetz, PhD(Co-founder & CSO)
Co-investorsBlue Bear VenturesForeground CapitalFuture VenturesNorth South VenturesPortfoliaOlive Tree Capital+1 more
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.









































